ARCHIVES

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Committee Holds Up RFP For Frederick, Asks Six Month Delay

September 24, 1976

Includes April issue of Business & Regulatory Report (8 pages).

May 2, 2003

Three Nominated To ET2; NCI Seeks Clinical Applications

May 24, 1991

Informatics: Gore Helps NCI Open CGAP Website

August 8, 1997

More RFPs For Smoking/Health Projects Planned For Release As Subcontracts For Enviro Control

March 14, 1975

NCI Programs: Four Awarded Grants For Chem-Bio Centers; NCI To Commit $20M For Cancer Informatics Infrastructure

October 23, 1998